| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From the Centre de Pneumologie de l'Hôpital Laval, Université Laval, Sainte-Foy, Québec, Canada
Background: Misunderstanding of the role of asthma medication and fear of untoward side effects may reduce compliance to therapy, potentially resulting in poor asthma control and increased risk of severe asthma events.
Methods: We report the results of a recent Canadian survey of 603 asthmatic patients recruited from the general population, aimed at determining their perception of the role and potential side effects of inhaled corticosteroids (ICS).
Results: The survey revealed that a large proportion of asthmatic patients do not understand the role of their medications and have many misconceptions and fears in regard to ICS, reducing their willingness to use them. Among the most common fears are those concerning troublesome side effects, particularly in regard to corporeal image, bone density, and a reduction in efficacy of medication over time. More than half of the population said they were very or somewhat concerned using ICS on a regular basis; two thirds of patients had not discussed their concerns about ICS with their physicians or other health-care professionals. Finally, in a large number of asthma patients, asthma was not adequately controlled, according to recent asthma consensus guidelines.
Conclusions: These observations stress the importance for those involved in asthma care of questioning patients about their understanding of the role of asthma medications, particularly ICS, their fears and misconceptions, and what they consider to be adequate asthma control, in order to provide appropriate education and counseling.
Key Words: asthma • asthma treatment • compliance • education • inhaled corticosteroids • patients' perception
Submitted on February 27, 1997
Accepted on September 10, 1000
This article has been cited by other articles:
|
|
 |
|
  L. v. d. Nieuwenhof, T. Schermer, P. Eysink, E. Halet, C. van Weel, P. Bindels, and B. Bottema Can the Asthma Control Questionnaire be used to differentiate between patients with controlled and uncontrolled asthma symptoms? A pilot study Fam. Pract., December 1, 2006; 23(6): 674 - 681. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Derendorf, R. Nave, A. Drollmann, F. Cerasoli, and W. Wurst Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma. Eur. Respir. J., November 1, 2006; 28(5): 1042 - 1050. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Schuh, P. T. Dick, D. Stephens, M. Hartley, S. Khaikin, L. Rodrigues, and A. L. Coates High-Dose Inhaled Fluticasone Does Not Replace Oral Prednisolone in Children With Mild to Moderate Acute Asthma Pediatrics, August 1, 2006; 118(2): 644 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Rand Patient adherence with COPD therapy Eur. Respir. Rev., December 1, 2005; 14(96): 97 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. George, D. C. M. Kong, R. Thoman, and K. Stewart Factors Associated With Medication Nonadherence in Patients With COPD Chest, November 1, 2005; 128(5): 3198 - 3204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.K. Reddel Goals of asthma treatment: how high should we go? Eur. Respir. J., November 1, 2004; 24(5): 715 - 717. [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Schaffer and L. Tian Promoting Adherence: Effects of Theory-Based Asthma Education Clin Nurs Res, February 1, 2004; 13(1): 69 - 89. [Abstract] [PDF]
|
|
|
|
|
|
F. M. Ducharme, G. Chabot, C. Polychronakos, F. Glorieux, and B. Mazer Safety Profile of Frequent Short Courses of Oral Glucocorticoids in Acute Pediatric Asthma: Impact on Bone Metabolism, Bone Density, and Adrenal Function Pediatrics, February 1, 2003; 111(2): 376 - 383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Maziak, E. von Mutius, C. Beimfohr, T. Hirsch, W. Leupold, U. Keil, and S.K. Weiland The management of childhood asthma in the community Eur. Respir. J., December 1, 2002; 20(6): 1476 - 1482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Pinto Pereira, Y. Clement, C. K. Da Silva, D. McIntosh, and D. T. Simeon Understanding and Use of Inhaler Medication by Asthmatics in Specialty Care in Trinidad* : A Study Following Development of Caribbean Guidelines for Asthma Management and Prevention Chest, June 1, 2002; 121(6): 1833 - 1840. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Dinwiddie and W G Muller Adolescent treatment compliance in asthma J R Soc Med, January 2, 2002; 95(2): 68 - 71. [Full Text] [PDF]
|
|
|
|
 |
|
 J C Kips and R A Pauwels Low dose inhaled corticosteroids and the prevention of death from asthma Thorax, September 1, 2001; 56(90002): ii74 - 78. [Full Text] [PDF]
|
|
|
|
|
|
R. Blais, J.-P. Gregoire, R. Rouleau, A. Cartier, J. Bouchard, and L.-P. Boulet Ambulatory Use of Inhaled {beta}2-Agonists for the Treatment of Asthma in Quebec : A Population-Based Utilization Review Chest, May 1, 2001; 119(5): 1316 - 1321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. H. Rowe, G. W. Bota, L. Fabris, S. A. Therrien, R. A. Milner, and J. Jacono Inhaled Budesonide in Addition to Oral Corticosteroids to Prevent Asthma Relapse Following Discharge From the Emergency Department: A Randomized Controlled Trial JAMA, June 9, 1999; 281(22): 2119 - 2126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Asthmatics' Misconceptions About Inhaled Steroids Journal Watch Emergency Medicine, May 1, 1998; 1998(501): 10 - 10. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
